Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer
Serum Thioredoxin Reductase Activity Research in First-line Chemotherapy Advanced Non-small Cell Lung Cancer
Sponsor: Hunan Province Tumor Hospital
Listed as NCT01980212, this observational or N/A phase trial focuses on Advanced Non-small Cell Lung Cancer and Carcinoembryonic Antigen and remains completed. Sponsored by Hunan Province Tumor Hospital, it has been updated 12 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Apr 2020 — Nov 2020 [monthly]
Completed
Status: Unknown Status → Completed
-
Jun 2018 — Apr 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Aug 2017 — Mar 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hunan Province Tumor Hospital
For direct contact, visit the study record on ClinicalTrials.gov .